IL-18 is a member of the IL-1 family of cytokines, which is highly expressed in intestinal epithelial cells (IECs). Upon barrier breach, IL-18 is matured to its bioactive form as a result of inflammasome activation, released from the cell via Gasdermin D pores, and sensed by IL-18 receptor 1-positive (IL18R1+) immune cells to initiate an inflammatory response. In addition to this epithelial-out signaling network, we recently uncovered an epithelial-intrinsic IL-18 signaling pathway in the murine small intestine and identified enterochromaffin cells and revival stem cells (revSC) as IL18R1+ bearing IEC populations in the recovering crypt. Here, we discuss the mechanism, and physiological relevance, as well as some of the open questions presented by this discovery in relation to intestinal health and disease.
Get full access to this article
View all access options for this article.
References
1.
AyyazA, KumarS, SangiorgiB, et al.Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. Nature, 2019; 569(7754):121–125; doi: 10.1038/s41586-019-1154-y
2.
CalafioreM, FuYY, VinciP, et al.A tissue-intrinsic IL-33/EGF circuit promotes epithelial regeneration after intestinal injury. Nat Commun, 2023; 14(1):5411; doi: 10.1038/s41467-023-40993-5
3.
ChaiQ, YuS, ZhongY, et al.A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin. Science, 2022; 378(6616):eabq0132; doi: 10.1126/science.abq0132
4.
ChenL, QiuX, DupreA, et al.TGFB1 induces fetal reprogramming and enhances intestinal regeneration. Cell Stem Cell, 2023; 30(11):1520–1537; doi: 10.1016/j.stem.2023.09.015
5.
ChungLK, ParkYH, ZhengY, et al.The yersinia virulence factor YopM hijacks host kinases to inhibit type III effector-triggered activation of the pyrin inflammasome. Cell Host Microbe, 2016; 20(3):296–306; doi: 10.1016/j.chom.2016.07.018
6.
FattingerSA, GeiserP, Samperio VentayolP, et al.Epithelium-autonomous NAIP/NLRC4 prevents TNF-driven inflammatory destruction of the gut epithelial barrier in Salmonella-infected mice. Mucosal Immunol, 2021; 14(3):615–629; doi: 10.1038/s41385-021-00381-y
KampferH, KalinaU, MuhlH, et al.Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol, 1999; 113(3):369–374; doi: 10.1046/j.1523-1747.1999.00704.x
9.
KaurD, ChachiL, GomezE, et al.Interleukin-18, IL-18 binding protein and IL-18 receptor expression in asthma: A hypothesis showing IL-18 promotes epithelial cell differentiation. Clin Transl Immunology, 2021; 10(6):e1301; doi: 10.1002/cti2.1301
10.
LuchettiG, RoncaioliJL, ChavezRA, et al.Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection. Cell Host Microbe, 2021; 29(10):1521–1530; doi: 10.1016/j.chom.2021.08.010
11.
NowarskiR, JacksonR, GaglianiN, et al.Epithelial IL-18 equilibrium controls barrier function in colitis. Cell, 2015; 163(6):1444–1456; doi: 10.1016/j.cell.2015.10.072
12.
OkamuraH, KashiwamuraS, TsutsuiH, et al.Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol, 1998; 10(3):259–264; doi: 10.1016/s0952-7915(98)80163-5
13.
PizarroTT, MichieMH, BentzM, et al.IL-18, a novel immunoregulatory cytokine, is up-regulated in crohn’s disease: Expression and localization in intestinal mucosal cells. J Immunol, 1999; 162(11):6829–6835.
RauchI, DeetsKA, JiDX, et al.NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8. Immunity, 2017; 46(4):649–659; doi: 10.1016/j.immuni.2017.03.016
16.
RoulisM, KaklamanosA, SchernthannerM, et al.Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. Nature, 2020; 580(7804):524–529; doi: 10.1038/s41586-020-2166-3
17.
SchumacherMA, ThaiMH, HsiehJJ, et al.Wnt/beta-catenin maintains epithelial IL-33 in the colonic stem and progenitor cell niche and drives its induction in colitis. Mucosal Immunol, 2025; 18(1):248–256; doi: 10.1016/j.mucimm.2024.11.007
18.
SellinME, MullerAA, FelmyB, et al.Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe, 2014; 16(2):237–248; doi: 10.1016/j.chom.2014.07.001
19.
SuQ, LuY, HeS, et al.Assessing inflammatory protein factors in inflammatory bowel disease using multivariable mendelian randomization. Sci Rep, 2025; 15(1):210; doi: 10.1038/s41598-024-84447-4
20.
TsangDKL, WangRJ, De SaO, et al.A single cell survey of the microbial impacts on the mouse small intestinal epithelium. Gut Microbes, 2022; 14(1):2108281; doi: 10.1080/19490976.2022.2108281
21.
VictorAR, NalinAP, DongW, et al.IL-18 drives ILC3 proliferation and promotes IL-22 production via NF-kappaB. J Immunol, 2017; 199(7):2333–2342; doi: 10.4049/jimmunol.1601554
22.
WinsorNJ, TsangDK, RangerA, et al.The IL-18 receptor is expressed on murine small-intestinal enterochromaffin cells and executes a recovery program upon injury. Proc Natl Acad Sci U S A, 2025; 122(22):e2417149122; doi: 10.1073/pnas.2417149122
23.
ZhangJ, BrodskyIE, ShinS. Yersinia deploys type III-secreted effectors to evade caspase-4 inflammasome activation in human cells. mBio, 2023; 14(5):e0131023; doi: 10.1128/mbio.01310-23
